Annovis Bio

/Annovis Bio

IPO

Annovis Bio

Pharmaceutical

Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD).

Symbol

ANVS

Price Range
$6.00 - $8.00

Final Shares
1,428,571

Anticipated Date
January 29, 2020

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Annovis Bio IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277